ABVC (ABVC BioPharma, Inc.) Rega marang bathi mangsa ngarep
Flexible asset management and global trials at ABVC BioPharma are creating intrigue surrounding the business valuation. The company's consensus P/E forecast helps track valuation anomalies, where 0.00 shows the current value of the metric. AI-driven laboratory robotics and a plant-based drug licensing strategy, which allows the company to avoid direct price wars in the market, provide the foundation for stability.
Ringkesan rincian data analitis ABVC BioPharma, Inc (ABVC)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal ABVC BioPharma|ABVC - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas ABVC BioPharma|ABVC - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku ABVC BioPharma Inc.|ABVC - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan ABVC BioPharma|Indikator likuiditas cepet abvcpharma.com
- rincian asil keuangan lan kelipatan valuasi:
ABVC - Bathi resik perusahaan|Proyeksi bathi mangsa ngarep ABVC BioPharma|ABVC - Koefisien rega marang bathi|Prakiraan rega marang bathi ABVC BioPharma Inc|ABVC - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA ABVC BioPharma Inc.|ABVC - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) ABVC BioPharma|ABVC - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan abvcpharma.com|ABVC - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ABVC BioPharma
Pambiji fundamental:ABVC BioPharma, Inc.
The resilience of ABVC BioPharma (ABVC) against pressure from pharmaceutical behemoths in the natural products niche depends on the precise execution of its financial plans. By analyzing the company's forward P/E ratio, an investor assesses the current market value of the business relative to expected net income, where an inflated multiple signals a risk of correction, while an excessively low one indicates potential stagnation of investment capital.
Analisis perusahaan pesaing
Prakiraan rega marang bathi HLN (Haleon)|KVUE (Kenvue Inc) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma Corp VRNA|Jyong Bio (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|amneal.com - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech S.A. - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Technologies) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Galapagos Corp GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AMPH (Amphastar Pharmaceuticals, Inc.)|Pangali Forward P/E Pacira Pharmaceuticals PCRX|ARS Pharma - Pangali Forward P/E|TBPH: Rega marang bathi mangsa ngarep|AQST (Aquestive Therapeutics) - Prakiraan rega marang bathi|SCPH (scPharmaceuticals) - Rega marang bathi mangsa ngarep|TECX (Tectonic Therapeutic Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi Tonix Pharma (TNXP)|Prakiraan rega marang bathi SXTC (China SXT Pharmaceuticals)|EPRX (eupraxiapharma.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E BHST (BioHarvest Sciences)|invizyne.com - Rega marang bathi mangsa ngarep|Oramed Pharma - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Entera Bio Ltd. ENTX|MindWalk (HYFT) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Cumberland Corp (CPIX)|Rega marang bathi mangsa ngarep Quantum BioPharma Ltd|fibrogen.com - Rasio rega marang bathi sing dikarepake|Pangali Forward P/E TELO|RANI (ranitherapeutics.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E SNYR (Synergy CHC)|Pangali Forward P/E Rallybio Corp RLYB|LEXX - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi PULM (pulmatrix.com)|ftzy.com.cn (PTHL) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Aptorum Group|LYRA (Lyra Therapeutics, Inc) - Pangali Forward P/E|Pangali Forward P/E Impact BioMedical, Inc.|Pangali Forward P/E TNFA|Pangali Forward P/E cbdmd.com (YCBD)|Pangali Forward P/E PRFX (PainReform)|Altamira Therapeutics Ltd - Rega marang bathi mangsa ngarep|LIPO: Prakiraan rega marang bathi|OPTN: Rega marang bathi mangsa ngarep|PIRS: Pangali Forward P/E|Prakiraan rega marang bathi procapsgroup.com|Rega marang bathi mangsa ngarep Petros Pharmaceuticals, Inc.|Qilian International Holding Group - Rasio rega marang bathi sing dikarepake|Pangali Forward P/E SLRN|TFFP (TFF Pharmaceuticals, Inc) - Pangali mangsa ngarep rega marang bathi
